Showing results (81-90 of 2,878) with videos related to
Sort By:
Pageof 288
Current Treatment Options in Neurology|February 11, 2015
Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial FibrillationQinmei Xiong, Gregory Y H LipCurrent Cardiology Reviews|August 28, 2012
Stroke prevention in atrial fibrillation: concepts and controversiesYousif Ahmad, Gregory Y H LipAnnals of Internal Medicine|May 1, 2023
In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause deathMichael Griffin, Gregory Y H LipAnnals of Internal Medicine|August 4, 2025
In uncontrolled hypertension, adding lorundrostat to a standardized AHT regimen reduced SBP at 12 wkAlena Shantsila, Gregory Y H Lip, Annals of Internal Medicine|March 31, 2025
In HF with mildly reduced or preserved ejection fraction, finerenone reduced CV death and worsening HF, regardless of baseline LVEFYang Wang, Gregory Y H Lip, The American Journal of Medicine|July 27, 2010
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?Gregory Y H Lip, Deirdre A LaneCurrent Pharmaceutical Design|September 23, 2010
Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillationTatjana S Potpara, Gregory Y H LipJAMA|May 20, 2015
Stroke prevention in atrial fibrillation: a systematic reviewGregory Y H Lip, Deirdre A LaneJournal of Atrial Fibrillation|December 14, 2016
Management of Atrial Fibrillation in Patients With Kidney DiseaseYee C Lau, Gregory Y H LipExpert Opinion on Investigational Drugs|October 31, 2003
Platelets, atherosclerosis and the endothelium: new therapeutic targets?Kiat Tsong Tan, Gregory Y H LipPageof 288